|
|
Post by pantaloons on Jan 25, 2018 13:18:53 GMT -5
Did Al Mann ever provide an estimate of the max market cap for MNKD?
|
|
|
|
Post by guidepost on Jan 25, 2018 13:21:58 GMT -5
Now the $64 question is: who's going to have the cojones to sell after the big run-up and wait for the "inevitable" decline to buy again? My sell-at-4 order went through  |
|
|
|
Post by mytakeonit on Jan 25, 2018 13:22:17 GMT -5
Quick ... buy it back !!! Or ... sucker!
|
|
|
|
Post by peppy on Jan 25, 2018 13:24:46 GMT -5
ad nauseam the monthly chart, the month is not closed yet. the monthly reversal. price took out the last two months of price action. the month has 4 more trading days to close. looking for targets. $5.00 is hard resistance. $7.37 is the only target I can semi come up with. 
|
|
|
|
Post by peppy on Jan 25, 2018 13:26:19 GMT -5
Did Al Mann ever provide an estimate of the max market cap for MNKD? I remember a 2.5 billion market cap with sanofi announcement. |
|
|
|
Post by thekid2499 on Jan 25, 2018 13:27:14 GMT -5
This is a replay. They are going to run it up and then dilute. I hope I'm wrong, but that is my best guess. I'm obviously happy to see this but I would love for it to be b/c of a partnership or parabolic script growth reported tomorrow.
|
|
|
|
Post by ezrasfund on Jan 25, 2018 13:32:40 GMT -5
Just got the call that Schwab is looking for more shares to lend. This is a roller coaster ride as usual, but when the last stock offering was set at $6 I don't think they just picked that number out of a hat.
|
|
|
|
Post by tw12 on Jan 25, 2018 13:33:01 GMT -5
Peppy: I just want to say "thank you!" for your tireless charts and comments. Though I'm not in any manner a technical investor (I'm an idealist, after all), your insights and observations read like financial poetry -- a bit mysterious but somehow still brilliantly informative. Onward!
|
|
|
|
Post by mango on Jan 25, 2018 13:36:12 GMT -5
|
|
|
|
Post by uvula on Jan 25, 2018 13:37:01 GMT -5
This is a replay. They are going to run it up and then dilute. I hope I'm wrong, but that is my best guess. I'm obviously happy to see this but I would love for it to be b/c of a partnership or parabolic script growth reported tomorrow. But last time analysts increased the target price and openly pumped the stock. That didn't happen this time. I hope this is something real but I've been burned too many times by this stock to buy more on speculation just to try to lower my avg cost. |
|
|
|
Post by mnkdfann on Jan 25, 2018 13:44:36 GMT -5
I know the standard claim is that Deerfield shorts, then covers with shares it gets from MNKD at a discount.
Just to change it up, perhaps Deerfield (or its proxies) manufactured a rally to sell its newly acquired shares into strength this time around?
|
|
|
|
Post by dreamboatcruise on Jan 25, 2018 13:45:01 GMT -5
Did Al Mann ever provide an estimate of the max market cap for MNKD? MNKD sold off a promising oncology line. Need to evaluate MNKD based on today, not what it was 10 years ago. |
|
|
|
Post by awesomo on Jan 25, 2018 13:48:59 GMT -5
During the last increase, there was a more gradual increase in volume, a couple days in the 10-20M range. This time it is coming out of the gate hot, looking like a 35-40M day.
|
|
|
|
Post by celo on Jan 25, 2018 13:52:30 GMT -5
ad nauseam the monthly chart, the month is not closed yet. the monthly reversal. price took out the last two months of price action. the month has 4 more trading days to close. looking for targets. $5.00 is hard resistance. $7.37 is the only target I can semi come up with.
I love that monthly chart. You could make an argument pretty easily that we have entered a new channel upward. Love to see the price go to 7.5 and 10 and hang out there for a while |
|
|
|
Post by seanismorris on Jan 25, 2018 13:54:13 GMT -5
Priorities:
1. Better Afrezza coverage
2. Massive scripts jump (tomorrow)
3. Global Afrezza partnership (with cash)
4. Technospere partner (with cash)
I have coverage #1 because it would make #2 sustainable...
Looks like the sellers came out in force at $4, we need some news...
With no news, the selling is understandable... scripts haven’t been impressive (yet).
|
|
